Akero Therapeutics to Present at Evercore ISI 3rd Annual HealthCONx Virtual Conference
Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today announced that management will participate in a fireside chat at Evercore's 3rd Annual HealthCONx virtual conference at 11:20 a.m. ET on Thursday, December 3, 2020.
A live webcast of the fireside chat and Q&A will be available through the investor relations section of the Company's website at www.akerotx.com. Following the live webcast, an archived replay will be available on the Company's website for 30 days.
About Akero Therapeutics
Akero is a cardio-metabolic NASH company dedicated to reversing the escalating NASH epidemic by developing pioneering medicines designed to restore metabolic balance to improve overall health. The company's lead product candidate, Efruxifermin (EFX), formerly known as AKR-001, is currently being evaluated in an ongoing Phase 2a clinical trial. Akero Therapeutics is headquartered in South San Francisco, CA. For more information, please visit www.akerotx.com.
LUXE Bidet, the #1 bidet attachment provider in America, is delighted to share its recent success at the esteemed Hermes Creative Awards for its project "LUXE Bidet ? Good Clean Fun," featuring a host-read with Conan O'Brien. The company's...
ApolloMD has announced today that it is a 2024 Top Workplaces Culture Excellence winner by Energage, a purpose-driven organization that develops solutions to build and brand Top Workplaces. The Top Workplaces program has a 17-year history of...
Watercrest Senior Living Group proudly announces the promotion of James Brassard to a new executive leadership role as Director of Market Street Operations. Market Street Memory Care Residences are luxury communities purposefully designed and...
Claudia Black, PhD, and Meadows Behavioral Healthcare are proud to announce the release of Undaunted Hope, featuring a foreword by Bessel van der Kolk, MD, author of the New York Times bestseller The Body Keeps the Score....
The "Elastomers: Applications and Global Markets" report has been added to ResearchAndMarkets.com's offering.
The Global Elastomers Market was valued at USD 105 Billion in 2023 and is expected to grow to USD 153.5 Billion in 2028, rising at a CAGR...
Getlabs, the nationwide leader in at-home diagnostics collection, has joined forces with Inocras, a leading AI-driven whole genome testing company that empowers patients with critical genetic insights for cancer and rare diseases....
